Maccabi Healthcare Services Launches Annual Flu Vaccination Campaign

Maccabi Healthcare Services has initiated its annual influenza vaccination campaign this week, aiming to protect the public ahead of the winter season. Approximately 250,000 vaccine doses have been ordered, including a high-dose vaccine for individuals over 65 and a standard inactivated vaccine administered via injection. A nasal spray vaccine (FluMist) for ages two to 49 will also be available later.

Vaccines are gradually arriving at Maccabi clinics nationwide and will continue to be distributed until the Sukkot holiday. Suwar Matta-Kassis, head nurse for Maccabi in the Northern region, urged members to get vaccinated early to build immunity before the peak of winter, emphasizing that full protection develops about two weeks after inoculation.

Global production and supply chain issues, stemming from an updated vaccine formula, have caused a delay in vaccine availability in Israel. Hagar Waxler, director of nursing at Maccabi, advised members to book appointments in advance, noting that larger quantities are expected in October. She highlighted that last year saw significant infection rates and hospital strain, underscoring the importance of early vaccination.

Dr. David Shasha, an infectious disease specialist at Maccabi, stated that while influenza season is not expected to be exceptionally severe in terms of overall cases, there is a notable rise in infections among children. He cautioned that data from the Southern Hemisphere is only an indicator and the virus can change. Children under five are particularly at risk for complications, and last year saw healthy children die from influenza complications. Despite viral mutations, the vaccine provided over 50% protection last year, which is crucial for high-risk groups.

Maccabi members can schedule appointments through the organization's website, app, or by calling *3833, and are advised to book in advance and check vaccine availability.